文献速递免疫规划妇幼与学校卫生传染病防控与疫情报告

2018-2023年中国江苏省苏州市孕期或产后早期实验室确诊流感住院情况

Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period - Suzhou City, Jiangsu Province, China, 2018-2023.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2024-10-31

基于苏州市2018年10月至2023年9月的人口主动监测,孕妇或产后<2周女性急性呼吸道或发热性疾病(ARFI)年住院率为11.1/1000活产,实验室确诊流感相关ARFI年住院率为2.1/1000活产。多数患者收入产科而非呼吸科,仅0.03%接种过流感疫苗,31.3%接受抗病毒治疗。

要点

  • 孕妇或产后<2周女性流感相关ARFI年住院率为2.1/1000活产。
  • 82.6%的ARFI住院和85.5%的流感ARFI住院患者收入产科病房。
  • 仅0.03%的ARFI住院孕妇或产后患者接种过流感疫苗,31.3%的流感ARFI住院患者接受抗病毒治疗。

核心结论

  • 研究结果凸显孕妇和产后女性流感及相关并发症风险、孕妇流感疫苗接种率低以及产科和妇科病房ARFI患者抗病毒治疗率低。

研究设计与样本

  • 2018年10月至2023年9月在苏州市开展基于人群的主动监测,纳入孕期或产后<2周女性。

主要发现

  • 孕妇或产后<2周女性ARFI年住院率为11.1/1000活产,实验室确诊流感相关ARFI年住院率为2.1/1000活产。
  • ARFI住院患者中82.6%(2588/3133)收入产科病房,流感ARFI住院患者中85.5%(423/495)收入产科病房。
  • 仅1例(0.03%)孕妇或产后ARFI患者接种过流感疫苗。
  • 31.3%的流感ARFI住院孕妇或产后女性接受抗病毒治疗。
  • 产科病房流感ARFI住院患者接受抗病毒治疗比例最低(29.6%),妇科病房为23.1%,呼吸科病房为54.1%。

临床怎么用

  • 提高对孕妇流感ARFI患病率的认识、对ARFI使用经验性抗病毒治疗以及流感季节产科病房的感染控制可能有助于降低孕妇和产后女性流感相关发病率。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pregnancy is associated with increased risk for severe illness and complications associated with influenza infection. Insufficient knowledge about the risk for influenza among pregnant women and their health care providers in China is an important barrier to increasing influenza vaccination coverage and treating influenza and its complications among pregnant women. Improved influenza incidence estimates might promote wider vaccine acceptance and higher vaccination coverage. In Suzhou, active population-based surveillance during October 2018-September 2023 estimated that the annual rate of hospitalization for acute respiratory or febrile illness (ARFI) among women who were pregnant or <2 weeks postpartum was 11.1 per 1,000 live births; the annual rate of laboratory-confirmed influenza-associated ARFI (influenza ARFI) hospitalization in this group was 2.1 per 1,000 live births. A majority of hospitalized pregnant or early postpartum patients with ARFI (82.6%; 2,588 of 3,133) or influenza ARFI (85.5%; 423 of 495) were admitted to obstetrics wards rather than respiratory medicine wards. Only one (0.03%) pregnant or postpartum ARFI patient had received influenza vaccination, and 31.3% of pregnant or postpartum women hospitalized for influenza ARFI received antiviral treatment; the lowest percentage of hospitalized women with influenza ARFI who received antiviral treatment was among women admitted to obstetrics and gynecology wards (29.6% and 23.1%, respectively), compared with 54.1% of those admitted to a respiratory medicine ward. These findings highlight the risk for influenza and its associated complications among pregnant and postpartum women, the low rates of influenza vaccination among pregnant women, and of antiviral treatment of women with ARFI admitted to obstetrics and gynecology wards. Increasing awareness of the prevalence of influenza ARFI among pregnant women, the use of empiric antiviral treatment for ARFI, and the infection control in obstetrics wards during influenza seasons might help reduce influenza-associated morbidity among pregnant and postpartum women.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Sun J, Zhang Y, Zhou S, et al. Laboratory-Confirmed Influenza Hospitalizations During Pregnancy or the Early Postpartum Period - Suzhou City, Jiangsu Province, China, 2018-2023. MMWR Morb Mortal Wkly Rep. 2024. PMID: 39480696. doi:10.15585/mmwr.mm7343a1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。